We sold LNCR today and redeployed the cash. LNCR’s revenue and earnings growth has declined over the past two years. See PERT A graph (above). Lower federal reimbursement for supplemental oxygen has cut into its margins. We used the above stock selection guide in making this decision.
Company Description: Lincare Holdings is a leading provider of oxygen and respiratory services to home-based patients, who typically suffer from chronic obstructive pulmonary disease, such as emphysema, chronic bronchitis, or asthma. Products and services incl.: liquid oxygen systems, oxygen concentrators, nebulizers, respiratory medications, noninvasive ventilation, apnea monitors, ventilators, and continuous positive airway pressure devices. Also provides infusion therapy and home med. equip. 2003 dep. rate: 12.3%. Has about 7,375 empls. Off./dir. control 6.4% of com.; Capital Grp. Intl., 10.4%; GE Asset Mgmt., 7.4% (4/04 proxy). Chrmn., CEO & Pres.: John P. Byrnes. Inc: DE. Add: 19337 US 19 North, Ste 500, Clearwater, FL 34624. Tel: 727-530-7700. Internet: www.lincare.com.